Soligenix Stock Performance
| SNGX Stock | USD 1.38 0.04 2.82% |
The entity has a beta of 0.73, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Soligenix's returns are expected to increase less than the market. However, during the bear market, the loss of holding Soligenix is expected to be smaller as well. At this point, Soligenix has a negative expected return of -0.0943%. Please make sure to validate Soligenix's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Soligenix performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Soligenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Soligenix is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Last Split Factor 1:16 | Dividend Date 2016-10-07 | Last Split Date 2024-06-06 |
1 | Applying Wyckoff theory to Soligenix Inc. stock - 2025 Key Lessons Step-by-Step Trade Execution Guides - newser.com | 11/05/2025 |
2 | Soligenix completes enrollment of patients for Phase 3 study evaluating HyBryte SNGX | 11/19/2025 |
3 | SNGX Phase 3 FLASH2 Trial Enrolls 50th Patient Interim Analysis in 2Q26 | 11/20/2025 |
4 | Acquisition by Parks Diane L. of 17647 shares of Soligenix at 1.7 subject to Rule 16b-3 | 11/21/2025 |
5 | Soligenix Elevates Advisory Network as Rare Disease Strategy Advance - The Globe and Mail | 11/26/2025 |
6 | Soligenix Inc. Innovative Platform Provides Novel Treatment for Underserved CTCL Space | 12/03/2025 |
7 | Soligenix Inc. Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad | 12/05/2025 |
8 | Acquisition by Christopher Schaber of 200000 shares of Soligenix at 1.63 subject to Rule 16b-3 | 12/11/2025 |
9 | Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behets Disease Published in Rheumatology | 12/18/2025 |
10 | Ideas Watch Can Soligenix Inc stock double in next 5 years - Weekly Trend Recap Verified Momentum Stock Watchlist - moha.gov.vn | 01/06/2026 |
11 | Acquisition by Christopher Schaber of 3530 shares of Soligenix at 1.4198 subject to Rule 16b-3 | 01/13/2026 |
12 | Soligenix Establishes At-The-Market Equity Offering Program - TipRanks | 01/23/2026 |
Soligenix | Build AI portfolio with Soligenix Stock |
Soligenix Relative Risk vs. Return Landscape
If you would invest 157.00 in Soligenix on October 29, 2025 and sell it today you would lose (19.00) from holding Soligenix or give up 12.1% of portfolio value over 90 days. Soligenix is currently does not generate positive expected returns and assumes 4.8861% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Soligenix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Soligenix Target Price Odds to finish over Current Price
The tendency of Soligenix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.38 | 90 days | 1.38 | about 73.77 |
Based on a normal probability distribution, the odds of Soligenix to move above the current price in 90 days from now is about 73.77 (This Soligenix probability density function shows the probability of Soligenix Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Soligenix has a beta of 0.73. This usually implies as returns on the market go up, Soligenix average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Soligenix will be expected to be much smaller as well. Additionally Soligenix has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Soligenix Price Density |
| Price |
Predictive Modules for Soligenix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Soligenix. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Soligenix Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Soligenix is not an exception. The market had few large corrections towards the Soligenix's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Soligenix, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Soligenix within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | 0.73 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.06 |
Soligenix Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Soligenix for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Soligenix can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Soligenix generated a negative expected return over the last 90 days | |
| Soligenix may become a speculative penny stock | |
| Soligenix has high historical volatility and very poor performance | |
| Soligenix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 119.37 K. Net Loss for the year was (8.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Soligenix currently holds about 20.16 M in cash with (8.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. | |
| Latest headline from thelincolnianonline.com: Pasithea Therapeutics Upgraded at Wall Street Zen |
Soligenix Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Soligenix Stock often depends not only on the future outlook of the current and potential Soligenix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Soligenix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.7 M | |
| Cash And Short Term Investments | 7.8 M |
Soligenix Fundamentals Growth
Soligenix Stock prices reflect investors' perceptions of the future prospects and financial health of Soligenix, and Soligenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Soligenix Stock performance.
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.69 | ||||
| Current Valuation | 2.87 M | ||||
| Shares Outstanding | 10.09 M | ||||
| Price To Earning | (1.67) X | ||||
| Price To Book | 1.71 X | ||||
| Price To Sales | 3,875 X | ||||
| Revenue | 119.37 K | ||||
| EBITDA | (9.46 M) | ||||
| Net Income | (8.27 M) | ||||
| Cash And Equivalents | 20.16 M | ||||
| Cash Per Share | 0.47 X | ||||
| Total Debt | 1.48 M | ||||
| Debt To Equity | 2.44 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (8.4 M) | ||||
| Earnings Per Share | (3.44) X | ||||
| Market Capitalization | 13.01 M | ||||
| Total Asset | 8.97 M | ||||
| Retained Earnings | (233.97 M) | ||||
| Working Capital | 3.98 M | ||||
| Current Asset | 7.15 M | ||||
| Current Liabilities | 7.41 M | ||||
About Soligenix Performance
Evaluating Soligenix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Soligenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Soligenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 12.12 | 14.54 | |
| Return On Tangible Assets | (0.83) | (0.87) | |
| Return On Capital Employed | (2.06) | (1.96) | |
| Return On Assets | (0.83) | (0.87) | |
| Return On Equity | (1.81) | (1.72) |
Things to note about Soligenix performance evaluation
Checking the ongoing alerts about Soligenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Soligenix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Soligenix generated a negative expected return over the last 90 days | |
| Soligenix may become a speculative penny stock | |
| Soligenix has high historical volatility and very poor performance | |
| Soligenix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 119.37 K. Net Loss for the year was (8.27 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Soligenix currently holds about 20.16 M in cash with (8.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47. | |
| Latest headline from thelincolnianonline.com: Pasithea Therapeutics Upgraded at Wall Street Zen |
- Analyzing Soligenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Soligenix's stock is overvalued or undervalued compared to its peers.
- Examining Soligenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Soligenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Soligenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Soligenix's stock. These opinions can provide insight into Soligenix's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Soligenix Stock Analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.